Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dyslipidemia in Patients With Diabetes Mellitus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT06129526
What this trial is testing

Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes

Who this might be right for
Diabetes Type 2HypertriglyceridemiaDiabetes Mellitus
University of Ioannina 450
Large-scale testing (Phase 3)Study completedNCT02827903
What this trial is testing

Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia

Who this might be right for
Type 2 DiabetesDyslipidemia
Jeil Pharmaceutical Co., Ltd. 237
Post-approval studies (Phase 4)Ended earlyNCT03258281
What this trial is testing

Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2Dyslipidemia Associated With Type II Diabetes MellitusPercutaneous Coronary Intervention
Inova Health Care Services 4
Post-approval studies (Phase 4)Study completedNCT00471549
What this trial is testing

Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Aarhus 18
Large-scale testing (Phase 3)Study completedNCT02585778
What this trial is testing

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

Who this might be right for
Hypercholesterolaemia
Sanofi 517
Not applicableLooking for participantsNCT03449784
What this trial is testing

Assessment of Compliance With European and French Guidelines for the Management of Dyslipidaemias

Who this might be right for
Patient With Dyslipidemia
University Hospital, Montpellier 977
Large-scale testing (Phase 3)Study completedNCT00349128
What this trial is testing

Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes

Who this might be right for
Dyslipidemia/Glucose Metabolism Disorder
Solvay Pharmaceuticals 382
Not applicableStudy completedNCT04125784
What this trial is testing

Lipid Profile and Diabetes Mellitus in People With HIV

Who this might be right for
HIV InfectionsDyslipidemiasDiabetes Mellitus+1 more
Moritz Oberndorfer 450
Not applicableStudy completedNCT02593032
What this trial is testing

Effects of Use of a Connected Pillbox On Medication Adherence

Who this might be right for
Diabetes MellitusHypertensionHyperlipidemia
University of Pennsylvania 50
Large-scale testing (Phase 3)Study completedNCT06548100
What this trial is testing

The Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)

Who this might be right for
Generalized Lipodystrophy
Regeneron Pharmaceuticals 9
Not applicableStudy completedNCT03502109
What this trial is testing

Pharmacist-led Medication Review With Follow-up on Primary Care Cardiovascular Older Adult Patients.

Who this might be right for
Cardiovascular DiseasesMedication AdherenceDrug Use+3 more
Pontificia Universidad Catolica de Chile 340
Post-approval studies (Phase 4)UnknownNCT00758927
What this trial is testing

The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2HypercholesterolemiaHypertriglyceridemia
Inje University 70
Early research (Phase 1)Study completedNCT01474161
What this trial is testing

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Who this might be right for
Type 2 DiabetesDiabetes Mellitus, Type 2Metabolic Diseases+3 more
Genfit 96
Not applicableEnded earlyNCT00477191
What this trial is testing

Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis

Who this might be right for
PsoriasisMetabolic SyndromeHyperlipidemia+2 more
Massachusetts General Hospital 18
Post-approval studies (Phase 4)Looking for participantsNCT05365425
What this trial is testing

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Who this might be right for
DyslipidemiaAtherosclerosisDiabetes Mellitus, Type 2
Seoul National University Bundang Hospital 56
Large-scale testing (Phase 3)Study completedNCT00236639
What this trial is testing

A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity

Who this might be right for
Obesity
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,293
Not applicableStudy completedNCT00419484
What this trial is testing

Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesHypertensionDyslipidemia+1 more
Dokkyo Medical University 1,000
Not applicableUnknownNCT00820378
What this trial is testing

The Epidemiology of Aortic Diameter in China

Who this might be right for
Vascular DiseaseDiabetesHypertension+1 more
Zhejiang University 2,000
Large-scale testing (Phase 3)Study completedNCT00770952
What this trial is testing

Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 91
Testing effectiveness (Phase 2)Study completedNCT00703755
What this trial is testing

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

Who this might be right for
Patients With Metabolic Syndrome
Solvay Pharmaceuticals 2,288
Next Page